West Pharmaceutical Services, I

Historical 13F Holders

Symbol
WST
CUSIP
955306105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 955306105 since 12/18/2024, newest first.

Filer % of Class Filed
FMR LLC 13G
5.0%
Checked 5% or less
8/6/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 7.5% 4/30/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 5.7% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 16 0% 3/27/2026
Event 3/13/2026
Vanguard Group Inc 13G/A Amendment 15 13.5% 10/31/2025
Event 9/30/2025
BlackRock, Inc. 13G/A Amendment 2 8.4% 4/24/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 82 804 k $287 M
2026 Q2 862 111 M $25.4 B
2026 Q1 777 71.1 M $17.8 B
2025 Q4 835 70.6 M $19.3 B
2025 Q3 790 69.1 M $18.1 B
2025 Q2 762 70.9 M $15.5 B
2025 Q1 749 69.9 M $15.6 B
2024 Q4 783 69.9 M $22.9 B
2024 Q3 774 69.7 M $20.8 B
2024 Q2 820 70.0 M $23.0 B
2024 Q1 820 70.9 M $28.0 B
2023 Q4 824 71.2 M $25.0 B
2023 Q3 796 68.9 M $25.9 B
2023 Q2 764 68.3 M $26.0 B
2023 Q1 726 69.7 M $24.1 B
2022 Q4 666 72.7 M $17.1 B
2022 Q3 666 68.7 M $16.9 B
2022 Q2 683 69.0 M $20.8 B
2022 Q1 753 70.9 M $28.4 B
2021 Q4 765 69.7 M $32.2 B
2021 Q3 703 67.4 M $28.5 B
2021 Q2 676 69.7 M $24.9 B
2021 Q1 615 68.9 M $19.3 B
2020 Q4 620 69.6 M $19.9 B
2020 Q3 597 68.6 M $18.8 B
2020 Q2 549 69.4 M $15.9 B
2020 Q1 493 68.3 M $10.4 B
2019 Q4 460 68.8 M $10.3 B
2019 Q3 434 67.5 M $9.57 B
2019 Q2 408 68.7 M $8.62 B
2019 Q1 399 68.3 M $7.53 B
2018 Q4 370 70.4 M $6.90 B
2018 Q3 372 70.2 M $8.65 B
2018 Q2 334 74.1 M $6.94 B
2018 Q1 329 70.7 M $6.24 B
2017 Q4 344 69.8 M $6.89 B
2017 Q3 308 69.8 M $6.72 B
2017 Q2 316 67.3 M $6.36 B
2017 Q1 302 67.8 M $5.53 B
2016 Q4 296 67.2 M $5.71 B
2016 Q3 285 66.2 M $4.93 B
2016 Q2 293 67.1 M $5.10 B
2016 Q1 258 68.5 M $4.75 B
2015 Q4 257 68.4 M $4.12 B
2015 Q3 255 68.5 M $3.71 B
2015 Q2 222 67.6 M $3.92 B
2015 Q1 217 67.4 M $4.05 B
2014 Q4 230 66.5 M $3.54 B
2014 Q3 220 66.7 M $2.98 B
2014 Q2 229 66.7 M $2.81 B
2014 Q1 229 63.6 M $2.80 B